← Back to news

Markets

ASOS Replaces Finance Chief Amid Turnaround Plan

Y

Häagen-Dazs, Starbucks Mull Overhauls in China to Fend Off Powerful Local Rivals

Y

Legal & General Flags Good Start to 2025, Confirms Targets

Y

Corn Prices Are Sliding. A Seasonal Slump Could Start Tuesday.

Y

'Deep pockets' could help Abu Dhabi win regulatory approval for Santos bid, analysts say

Y

GSK Licenses Shigella Vaccine to Bharat Biotech

Y

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating

Y

Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook

Y

Tenet Healthcare Corp (THC) on the Spot over Medicare Fraud Allegations

Y

Morgan Stanley Hikes McKesson (MCK) Price Target on Earnings Growth Prospects

Y

IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners

Y

Ascendis Pharma (ASND) Rated as a Hold at Cannacord Genuity on Growth Hormone Prospects

Y

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Y

Cigna (CI) Unveils AI-Powered Tools to Enhance Healthcare Delivery

Y

Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating

Y

AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C

Y

UBS Affirms Neutral Rating on Baxter International (BAX)

Y

AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics

Y

IAG: Earnings Jet To New Heights, Yet All-Time Highs Stay In The Hangar - Sell The Cycle-Peak

S

Tipping Points - How Will Markets Respond?

S

CoreWeave: Three Realistic Scenarios, Pick Yours

S

Nutrien: Not Attractive Enough To Justify Buying Yet

S

Berkshire Hathaway: Buffett's Out, Billions In Doubt

S

Conflict concerns weigh on indexes, bolster oil and US debt

Y

SoftBank raises $4.8 billion from T-Mobile share sale, term sheet shows

Y

Oil prices rise more than 4% as Iran-Israel conflict escalates

Y

Rob Arnott’s Firm Says the Time Is Finally Right for ‘Smart Beta’

Y

Boeing Could Avoid a Trial

Y

5 Safe Dividend Stocks Yielding Over 5% You Can Buy Without Hesitation Right Now for Passive Income

Y

2 Top Artificial Intelligence Stocks to Buy Right Now

Y

Dow Jones Futures Fall On Trump Iran Comments; Meta, Palantir, Nvidia, Tesla Rally

Y

Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push

Y

Circle's stock price surges after stunning CEO comment

Y

The stock market's secret weapon: Insatiable demand from American retirement accounts

Y

Nvidia (NVDA) Reaffirmed as AI Leader by Analysts — Mizuho Calls CUDA a ‘Fortress Moat’

Y

Apple (AAPL) Gets $235 Price Target from Morgan Stanley After China iPhone Demand Surprises

Y

Goldman Sachs Reiterates Buy on Adobe (ADBE) with $570 Target Amid Rising AI Momentum

Y

Anduril Founder Palmer Luckey, Palantir Co-Founder Joe Lonsdale To Invest In Crypto-Friendly Startup Bank: Report

Y

Tesla (TSLA)’s Strength in AI and Robotics Drives Morgan Stanley’s Bullish Outlook

Y

Advanced Micro Devices (AMD) Gets $130 Price Target as BofA Calls It the “Next-Best AI Vendor”

Y

Citi Sees Big Upside in Vertiv (VRT)— Here’s Why the Stock Now Has a $130 Price Target

Y

Oppenheimer Raises Meta Platforms (META) Target to $775 — But Is AI Still a Weak Spot?

Y

Amazon (AMZN) Commits $13B to AI Data Centers in Australia — Its Largest Tech Investment Yet

Y

Datadog (DDOG) Gets $120 Price Target from Stifel — Analyst Reiterates Hold

Y

UK invests $340 million in clean tech for air travel

Y

Jefferies Raises Twilio (TWLO)’s Price Target — But Cautions on Most Optimistic Forecasts

Y

Stock market today: Dow, S&P 500, Nasdaq futures fall as Trump dents Israel-Iran truce hopes amid escalating strikes

Y

Stock market today: Dow, S&P 500, Nasdaq futures fall as Trump comments ravage Israel-Iran truce hopes amid escalating strikes

Y

How the $1,000 ‘Trump Accounts’ Would Compare to Other Savings Plans

Y

This AI Pioneer Could Deliver $18 EPS by 2027 — Here’s Why Investors Are Buying IBM (IBM)

Y